| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
4,019 |
1,107 |
$185K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,878 |
3,022 |
$97K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
5,826 |
1,738 |
$70K |
| 99233 |
Prolong inpt eval add15 m |
2,660 |
980 |
$46K |
| 99223 |
Prolong inpt eval add15 m |
918 |
671 |
$35K |
| 94060 |
|
1,068 |
929 |
$25K |
| 94726 |
|
907 |
794 |
$20K |
| 94729 |
|
982 |
857 |
$20K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
793 |
653 |
$13K |
| 99215 |
Prolong outpt/office vis |
307 |
213 |
$10K |
| 99406 |
|
1,376 |
1,108 |
$5K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
554 |
228 |
$4K |
| 99222 |
Initial hospital care, per day, moderate complexity |
47 |
37 |
$2K |
| 99205 |
Prolong outpt/office vis |
15 |
13 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
12 |
$93.24 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
302 |
260 |
$56.47 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
115 |
100 |
$18.73 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
349 |
328 |
$14.88 |